Advisory Boards

FEMTECH ADVISORY BOARD

Our Femtech Advisory Board (FAB) is composed of leading plastic surgeons and experts in women’s health who provide clinical insight and strategic guidance in the development and adoption of innovative technologies in aesthetic and reconstructive breast surgery to Establishment Labs.

The Femtech Advisory Board collaborates closely with other Advisory Boards to ensure alignment across clinical practice, scientific development and innovation in women’s health.

Dr. KAMAKSHI
ZEIDLER

MD, FACSSEE MORE

Dr. ANNA
STEVE

MDSEE MORE

Dr. FEDERICO
FLAHERTY

MDSEE MORE

Dr. JERRY
CHIDESTER

MDSEE MORE

Dr. MARTINA
SCHNEIDER

MDSEE MORE

Dr. KAMAKSHI
ZEIDLER

MD, FACSSEE MORE

Dr. ANNA
STEVE

MDSEE MORE

Dr.FEDERICO
FLAHERTY

MDSEE MORE

Dr. JERRY
CHIDESTER

MDSEE MORE

Dr. MARTINA
SCHNEIDER

MDSEE MORE
Dr. KAMAKSHI

ZEIDLER

MD, FACS
SEE MORE
Dr. ANNA

STEVE

MD
SEE MORE
Dr. FEDERICO

FLAHERTY

MD
SEE MORE
Dr. JERRY

CHIDESTER

MD
SEE MORE
Dr. MARTINA

SCHNEIDER

MD
SEE MORE

SCIENTIFIC ADVISORY BOARD

Our Scientific Advisory Board (SAB) is composed of world renowned experts from industry and academia who provide guidance and help Establishment Labs set strategic direction on scientific and technical topics associated with the science, development, manufacturing and quality of our solutions.

The Scientific Advisory Board works closely with the other Advisory Boards on matters which benefit from the overlapping expertise.

ROBERT
LANGER

PhDSEE MORE

ARDESHIR
BAYAT

MD & PhDSEE MORE

ARIKHA
MOSES

MD & PhDSEE MORE

PROF. MICHAEL
ATLAN

MD & PhDSEE MORE

ROBERT
LANGER

PhDSEE MORE

ARDESHIR
BAYAT

MD & PhDSEE MORE

ARIKHA
MOSES

MD & PhDSEE MORE

PROF. MICHAEL
ATLAN

MD & PhDSEE MORE
ROBERT
LANGER
PHD
SEE MORE
ARDESHIR
BAYAT
MD & PhD
SEE MORE
ARIKHA

MOSES

MD & PhD
SEE MORE
PROF. MICHAEL

ATLAN

MD & PhD
SEE MORE

MEDICAL ADVISORY BOARD

Our Medical Advisory Board brings together some of the world’s most respected contributors to Aesthetic and Plastic Surgery, recognized as leaders both in their respective region and internationally.

The Medical Advisory Board helps Establishment Labs in developing the highest standards for solutions and surgeries related to breast health, aesthetics, and reconstruction, securing patients’ safety and satisfaction.

DR ALEXANDRE
MUNHOZ

MDSEE MORE

DR DENNIS
HAMMOND

MDSEE MORE

DR NIAMH
CORDUFF

MDSEE MORE

DR ALEXANDRE
MUNHOZ

MDSEE MORE

DR DENNIS
HAMMOND

MDSEE MORE

DR NIAMH
CORDUFF

MDSEE MORE
DR ALEXANDRE

MUNHOZ

MD
SEE MORE
DR DENNIS

HAMMOND

MD
SEE MORE
DR NIAMH

CORDUFF

MD
SEE MORE
Reporting Hotline
Careers

ABOUT

DR. KAMAKSHI

ZEIDLER

MD, FACS

DR. KAMAKSHI

ZEIDLER

MD, FACS

Dr. Kamakshi Zeidler, the Chair of the Femtech Advisory Board, is a plastic and reconstructive surgeon based in the United States and a managing partner at AESTHETX in California. After acquiring her Bachelors of Art in Biology from Rice University, she completed her medical training at the University of California San Francisco, where she also completed residencies in general surgery and plastic and reconstructive surgery, as well as a postdoctoral research fellowship focused on stem cell applications in wound healing.

Dr. Zeidler is recognized for her expertise in both aesthetic and reconstructive breast surgery, as well as her work in advancing new technologies from research to clinical application. She is an active member of multiple professional organizations, including the American Society of Plastic Surgeons and the American Society for Reconstructive Microsurgery.

Dr. Zeidler provides the Femtech Advisory Board strategic leadership and clinical expertise to support the development of innovative solutions in women’s health and breast surgery.

ABOUT

DR. FEDERICO

FLAHERTY

MD

DR. FEDERICO

FLAHERTY

MD

Dr. Federico Flaherty is a plastic surgeon based in Argentina, specializing in aesthetic and reconstructive breast surgery. He completed his medical degree at the University of Buenos Aires and his surgical training in General and Plastic Surgery at Churruca Hospital. He is a member of the Argentine Society of Plastic Surgery (SACPER) and the Buenos Aires Society of Plastic Surgery (SCPBA), and from 2021 through 2022 was the Partner Society Associate Editor, Editorial Board of the Plastic and Reconstructive Surgery Journal.

Dr. Flaherty currently serves as Head of the Plastic Surgery Service at Otamendi Medical Center and co-director of its breast unit. He is also the founder and president of the Mamamia Foundation, focused on breast reconstruction, and the author of Breast Reconstruction: A Scientific Guide Inspired by Life Stories. Additionally, he holds numerous trainings and specializations in the United States, Spain and Brazil with leading references in the field.

His work is defined by surgical precision, a strong commitment to patient safety, and active involvement in international training and education. He brings a multidisciplinary perspective to advancing breast surgery and patient care.

ABOUT

PETER

CALDINI

Chief Executive Officer

PETER

CALDINI

Chief Executive Officer 

Peter Caldini joined the Company as the President in August 2024.  Prior to joining, Peter worked as a consultant with the Company’s leadership team to identify efficiencies and cost savings. Before that, Peter was the Chief Executive Officer at Acreage Holdings, Inc., a publicly traded company, from December 2020 to June 2023. Prior to that, he was the Chief Executive Officer and a director at Bespoke Capital Acquisition Corp., a special purpose acquisition corporation, from June 2019 until December 2020. Prior to that, he held positions of increasing responsibility at Pfizer, Inc., including Regional President North America for Pfizer Consumer Healthcare from 2017 to 2019; Regional President EMEA of Pfizer Consumer Healthcare from 2016 to 2017, and leader of the Northern European cluster from 2015 to 2016. From 2009 to 2014, Peter held roles of increasing responsibility at Bayer Consumer Healthcare, including leading the Global Nutritionals Strategic Business Unit and running a sub-region of emerging markets in EMEA. And from 2002 to 2009, he held roles of increasing responsibility at Wyeth Consumer Healthcare in the US and Internationally. Peter received a Masters of International Economics and Management from Bocconi University in Milan, Italy, an MBA from Northeastern University and a BA, Political Science from Boston University.

Learn more about:

ABOUT

PROF. MICHAEL

ATLAN

MD & PhD

PROF. MICHAEL

ATLAN

MD & PhD

Prof. Michael Atlan MD, Ph.D. is currently the chief of the Plastic and Reconstructive Surgery Department at TENON Hospital and a Professor at the Sorbonne Medecine Universite.

His main interests are Aesthetic Breast Surgery, breast reconstruction with ADM, Free Flaps for breast reconstruction, and Breast Cosmetic Surgery (anatomic implants, Fat Grafting). His areas of expertise include breast implant surface, the evaluation of new devices in plastic surgery, and Facial Aesthetic Surgery.

He is one of the founders of the CAMPUS CHAMPS ELYSEES.

ABOUT

DR FEDERICO

MAYO

MD

DR FEDERICO

MAYO

MD

Born in Spain in 1967, Dr. Mayo holds a degree in medicine and surgery from Universidad Complutense de Madrid, a doctorate in research skills from Universidad Complutense de Madrid, and a medical specialty in plastic aesthetic and reconstructive surgery since 2001, recognized by the UK. He is a member of the General Medical Council, validated in Switzerland and has professional experience in Zurich and currently in Madrid. 

He is the author of chapters in specialty books and his works have been published in renowned journals, such as Aesthetic Plastic Surgery and Plastic and Reconstructive Surgery. Dr. Mayo is an active member of the scientific society, including the Sociedad Española de Cirugía Estética y Plástica, the Asociación Española De Cirugía Estética, the International Society of Aesthetic Plastic Surgery, and the American Society of Plastic Surgery. He is a reviewer for the Aesthetic Plastic Surgery Journal and has patented ideas applicable in breast implant manufacturing. He has completed over 12,000 surgical interventions as primary surgeon and has implanted over 10,000 breast implants in more than 20 countries around the world as part of conferences, Masterclasses, and other scientific events.

ABOUT

DR NIAMH

CORDUFF

MD

DR NIAMH

CORDUFF

MD

Dr Niamh Corduff qualified from Charing Cross Medical School, the University of London, in 1984 and subsequently did her basic surgical training in the UK before emigrating to Australia in 1988. Dr Corduff completed her specialist plastic surgical training in Melbourne Australia and in 1993 became a Fellow of the Royal Australasian College of Surgeons. With more than 2 decades of experience, this Australian surgeon is a member and former president of the Australasian Society for Aesthetic Plastic Surgery and an honorary member of the Australian Society of Plastic Surgeons. Dr Corduff developed a special interest in breast surgery and since 2000 her surgical practice was focused solely on aesthetic and reconstructive breast surgery. She has published and lectured on aesthetic breast surgery both locally and internationally.

ABOUT

DR DENNIS

HAMMOND

MD

DR DENNIS

HAMMOND

MD

Dr. Dennis Hammond, a board-certified plastic surgeon by the American Board of Plastic Surgery, is one of the world’s most recognized and respected authorities in breast aesthetic and reconstructive surgery. He is a member of and has served on numerous committees for the American Society of Plastic Surgeons (ASPS) as well as for the American Society for Aesthetic Plastic Surgery (ASAPS), and is a member of the prestigious American Association of Plastic Surgeons.

Dr. Hammond has co-edited one of the most influential textbooks in plastic surgery along with his friend and colleague Dr. Scott Spear from Georgetown University in Washington DC. He has authored many scientific papers, and serves as a reviewer for scientific articles for Aesthetic Plastic Surgery, Plastic and Reconstructive surgery, and the Journal of Aesthetic Surgery.

Dr. Hammond has written “Atlas of Aesthetic Breast Surgery“, first published in 2009, a book which became a gold standard on how to perform new and innovative techniques for surgically and artistically augmenting, reshaping, lifting, and reducing the breast.

ABOUT

DR ALEXANDRE

MUNHOZ

MD

DR ALEXANDRE

MUNHOZ

MD

Dr. Alexandre Mendonça Munhoz, M.D., PhD. Is Assistant Professor of Plastic Surgery, Breast Surgery Division of Plastic Surgery at University of São Paulo School of Medicine in Sao Paolo,Brazil and a full member of the Brazilian Society of Plastic Surgery (SBCP). He participates as a guest member of the international consultants of Plastic and Reconstructive Surgery and Breast Journal since 2006.

In the period of 2010-2014 Dr. Munhoz took over a role of a permanent member of the editorial board of the Annals of Plastic Surgery and the coordination of the National Commission of Breast Reconstruction of Brazilian Society of Plastic Surgery.

Dr.Munhoz currently has 27 scientific awards related to plastic surgery research, 145 published scientific papers, being 124 indexed in PubMed platform, 93 publications as a first author and in the area of aesthetic and reconstructive breast surgery, which resulted in about the 2967 citations with H-Index of 29.

In 2013, he became Head of the Breast Reconstruction Department of the Cancer Institute of São Paulo (ICESP). In 2015, Dr. Munhoz took over the Department of Plastic Surgery of the Moriah Hospital. In 2016, he was elected by American Society of Plastic Surgery (ASPS) as Associated Editor of Plastic and Reconstructive Surgery Global Open Journal. In 2022, Dr. Munhoz became an International member of American Society of Plastic Surgery (ASPS) and a full member of International Society of Aesthetic Plastic Surgery (ISAPS).

ABOUT

DR JERRY

CHIDESTER

MD

DR JERRY

CHIDESTER

MD

Dr. Jerry Chidester is a board-certified plastic surgeon and co-founder and CEO of The Plastics Clinic and Spa in Draper, Utah. Based in the United States, he specializes in aesthetic breast and body surgery, with a focus on advanced breast procedures and breast-preserving augmentation techniques.

His clinical work is centered on delivering natural-looking results through innovative surgical approaches and a strong emphasis on patient-centered care. Dr. Chidester is actively engaged in advancing modern breast surgery techniques and contributes to the evolution of aesthetic practices through his clinical expertise and leadership.

ABOUT

ARIKHA

MOSES

MD & PhD

ARIKHA

MOSES

MD & PhD

Arikha is an experienced medical device executive and entrepreneur, whose companies developed products that have been implanted in millions of patients worldwide.  She was the founder and CEO of Galatea Surgical (now owned by Becton Dickinson), guiding the company from inception, through clinical studies and the commercial release of GalaFLEX© for soft tissue reinforcement.  She was also the founder and CSO of TyRx (now Medtronic Infection Control), which commercialized antibiotic eluting products for the prevention of infection associated with indwelling devices.  Over more than 20 years in the industry, Arikha has cultivated deep expertise in resorbable surgical products and the development of solutions to complications associated with implantable devices. Arikha is currently an investor and board member of several privately held medical companies and nonprofit organizations.  She has a PhD in Chemistry from Yale and a BA in Chemistry from Brandeis University.

ABOUT

DR. ANNA

STEVE

MD

DR. ANNA

STEVE

MD & Eng

Dr. Anna Steve is a New York City-based plastic surgeon specializing in aesthetic breast surgery, with a focus on natural-looking, small-volume augmentations. Her practice is defined by a patient-centered philosophy and the refinement of surgical techniques that prioritize subtle, proportionate results with minimal downtime.

In addition to her clinical work, Dr. Steve is an active speaker and educator, dedicated to improving communication between surgeons and patients. She is a member of the American Society of Plastic Surgeons and serves as a peer reviewer for Plastic & Reconstructive Surgery and PRS Global Open. She has also presented her work on breast implant technology and patient-centered outcomes at national and international plastic surgery conferences, as well as at academic and industry forums including Columbia Business School and NASDAQ Investors Day on behalf of Establishment Labs.

Dr. Steve has developed a particular expertise in advanced breast implant technologies, with a focus on the Motiva Preservé® Breast Augmentation technique and is actively involved in the techniques’ surgical education in the United States.

ABOUT

ARDESHIR

BAYAT

MD & PhD

ARDESHIR

BAYAT

MD & PhD

Prof. Ardeshir Bayat is Director of the Medical Research Council Wound Healing Unit and professor at the University of Cape Town, Cape Town in South Africa. He is considered an expert in wound healing, cutaneous repair and skin scarring, with internationally recognised expertise in implant surface technology, fibrosis and capsular contracture. He trained as a surgeon-scientist with a PhD in molecular genetics of fibrosis. He has published extensively in peer-reviewed scientific literature (in excess of 500 articles to date). He is regularly an invited speaker at both national and international tissue repair conferences (over 600 conferences to date) and serves on the editorial boards of several journals.

His team have created and patented novel biomimetic surfaces and continue to work on developing models to understand the process of cell surface interaction/capsular fibrosis and its modulation related to implant surfaces. His investigative work has enabled translation of basic science to therapeutic developments of direct relevance to both cosmetic patients and industry.

ABOUT

ROBERT

LANGER

PhD

ROBERT

LANGER

PhD

Robert Langer is an Institute Professor at MIT (there are 13 Institute Professors at MIT; an Institute Professor is the highest honour awarded to a faculty member). His h-index of 232 is the highest of any engineer in history. He has over 1,130 issued and pending patents which have been licensed or sublicensed to over 300 companies. He served as Chair of the FDA’s SCIENCE BOARD (highest advisory board) from 1999-2002.  Langer is one of a very few individuals elected to the National Academy of Medicine, the National Academy of Engineering, the National Academy of Sciences and the National Academy of Inventors.  He is one of four living individuals to receive both the US National Medal of Science and the US National Medal of Technology and Innovation.  In 2015, Dr Langer received the Queen Elizabeth Prize for Engineering.  He has also received the Draper Prize (considered the engineering Nobel Prize), Albany Medical Center Prize, Wolf Prize for Chemistry, Millennium Technology Prize, Priestley Medal (highest award of the American Chemical Society),  Gairdner Prize, Kyoto Prize and the Lemelson-MIT Prize, for being “one of history’s most prolific inventors in medicine”. He holds 29 honorary doctorates including honorary degrees from Harvard and Yale.

ABOUT

ROSS

MANSBACH
General Counsel & Chief Compliance Officer

ROSS

MANSBACH
General Counsel & Chief Compliance Officer

Ross Mansbach joined the company in August 2022 as the General Counsel and Chief Compliance Officer. He was previously at Avanos Medical, Inc., a publicly traded medical device company, where he held positions including Senior Vice President, Interim General Counsel and Corporate Secretary and Vice President, Deputy General Counsel and Corporate Secretary, between November 2014 and March 2022. Prior to that, Mr. Mansbach held positions of increasing responsibility in the Legal Department at Kimberly-Clark Corporation for more than ten years. Earlier in his career, Mr. Mansbach was a partner at the law firm of Powell Goldstein Frazer & Murphy, now known as Bryan Cave. He was also a judicial clerk for a United States District Court judge for the Northern District of Illinois. Mr. Mansbach received his B.A from Yale College and his J.D. from The University of Chicago.

Learn more about:

ABOUT

IVAN

BILIC

Senior Vice President of Commercial Operations – OUS

IVAN

BILIC

Senior Vice President of Commercial Operations – OUS

Mr. Bilic has been part of Establishment Labs® since April 8, 2019, and is dedicated to advancing women’s health through innovative technology. His career highlights include roles as senior commercial director for European distribution markets, vice president for EMEA, and his current position as senior vice president for OUS. Notable accomplishments include restructuring the commercial function and transforming the German market. In his current role, Mr. Bilic strategically leads Establishment Labs®‘ commercial efforts, overseeing both the channel and direct markets and shaping B2B and B2B2C strategies for market leadership. He represents Establishment Labs® in the non-U.S. plastic surgery market and drives innovative marketing approaches globally. Prior to joining Establishment Labs®, he held key positions at Polytech and Allergan and holds a Master of Business Administration from Hult International Business School.
Learn more about:

ABOUT

RAJ
DENHOY

Chief Financial Officer

RAJ

DENHOY

Chief Financial Officer

Raj has been part of Establishment Labs® since February 2021. Before his current role as SVP, Global Strategy, he served as the company’s Chief Financial Officer from 2021 to 2026. Raj joined the company from Jefferies Group, LLC where he was a Managing Director and led the U.S. medical device research team for eleven years, including coverage of Establishment Labs®. He covered the medical device industry as an equity research analyst for over twenty years. Raj has a bachelor’s degree in biology from UC Berkeley, a master’s degree in physiology from Georgetown University, and an MBA from Cornell University.
Learn more about:

ABOUT

ROBERTO

DE MEZERVILLE

Chief Technology Officer

ROBERTO

DE MEZERVILLE

Chief Technology Officer

Since 2009, Roberto has risen through several positions in our company, in the areas of quality management, research, regulatory and clinical affairs, and has been our CTO heading Research, Development, and Innovation since January 2018.

Roberto has led several impactful research projects that have been key to the science-based design of our FemTech technologies, and has authored peer-reviewed publications. From 2006 to 2009, served in various engineering and quality manager positions with Allergan Medical Costa Rica.

He has a bachelor’s degree in Business Administration from Universidad Interamericana de Costa Rica and a bachelor’s degree in Industrial Environmental Health and Safety Engineering from Instituto Tecnológico de Costa Rica.

Learn more about:

ABOUT

SANDRA

HARRIS

Chief Financial Officer

SANDRA

HARRIS

Chief Financial Officer

Sandra Harris serves as Chief Financial Officer of Establishment Labs®, where she leads the company’s global finance organization and supports strategic initiatives to drive profitable growth and long-term value creation.

Harris brings extensive financial leadership experience across global, publicly traded and private equity-backed companies. Most recently, she served as Senior Vice President, Finance and Chief Financial Officer of Genesco Inc. (NYSE: GCO), where she led all core financial functions and supported profitability and capital allocation initiatives. Previously, she was Chief Financial Officer of Artisan Design Group, where she strengthened financial controls.

From 2019 to 2022, Harris served as Chief Financial Officer and Chief Operating Officer of Tupperware Brands, where she led a comprehensive turnaround focused on cost reduction, liquidity improvement, leverage reduction, and the transition to an omnichannel, digitally enabled business model.

Harris joined Establishment Labs® in 2026 as the company advances into its next phase of growth, bringing deep expertise in financial strategy, operational execution, and transformation to support the company’s mission of improving women’s health and wellness through innovation.

Learn more about:

MELISSA

MOREIRA

Human Resources Global VP

MELISSA

MOREIRA

Human Resources Global VP

Melissa Moreira Amado joined Establishment Labs as Vice President of Global Human Resources in September 2025. Reporting to the Chief Executive Officer, she is responsible for the company’s global people strategy, in support of the company’s mission to transform women’s health worldwide.
Prior to joining Establishment Labs®, Ms. Moreira Amado served as Vice President of Global Shared Services at Bacardi, where she was responsible for setting the strategic direction and overseeing global shared services operations supporting Finance, Human Resources, and Supply Chain across multiple regions. She previously held the role of Global HR Director for Bacardi Shared Services.
Earlier in her career, Ms. Moreira Amado held senior human resources and talent leadership roles at Grupo Purdy Motor, adidas Group, British American Tobacco, and The Coca‑Cola Company, with responsibilities spanning Latin America, the Caribbean, and global operations.
Ms. Moreira Amado holds degrees in Economics and Psychology and is bilingual in English and Spanish
Learn more about:

ABOUT

DR. MARTINA

SCHNEIDER

MD

DR. MARTINA

SCHNEIDER

MD

Dr. Martina Schneider is a board-certified plastic surgeon specializing in aesthetic and reconstructive breast surgery, based in Zurich, Switzerland. She completed her surgical training at several leading institutions including the University Hospital Zurich, and obtained both Swiss and European board certifications in Plastic, Reconstructive, and Aesthetic Surgery.

Dr. Schneider is a core member of the Lake Zurich Breast Center, part of the BRST team, and a managing partner at Utoquai Clinic. Her work combines technical precision with a patient-centered approach, focusing on delivering individualized outcomes through advanced surgical techniques.

Her clinical practice reflects a strong commitment to innovation and excellence in breast surgery, with a focus on improving both functional and aesthetic outcomes for patients.

ABOUT

JEFF

EHRHARDT

SVP & General Manager – North America

JEFF

EHRHARDT

SVP & General Manager – North America

Mr. Ehrhardt joined the Establishment Labs® leadership team in April of 2024 after a distinguished career in Plastic Surgery and Dermatology in the U.S. market.  He was most recently VP and General Manager of the U.S. Plastic Surgery and Regenerative Medicine business unit for Allergan Aesthetics, an Abbvie company.  In his 26 plus years at Allergan he held various senior leadership roles such as VP U.S. Commercial Operations, VP of Sales Plastic Surgery & Regenerative Medicine and VP of Sales and Marketing, U.S. Dermatology.  Notably, he was head of Dermatology Sales for the launch of Botox Cosmetic, acquisition and merger of Lifecell into the U.S. Plastic Surgery organization, acquisition and launch of Aczone®, an acne product, and the launch of the Inspira® line of breast implants.   In his role at Establishment Labs®, he will be responsible for the commercialization of the Motiva® Femtech line of breast aesthetics devices in both the U.S. and Canada.   He holds undergraduate degrees in Finance and Marketing from the University of Cincinnati and an M.B.A. from Xavier University.
Learn more about:

ABOUT

JEFFREY
BETTINGER
Global Head of People

Jeffrey Bettinger joined Establishment Labs® in November 2021 from Nu Skin, a global leader in beauty and wellness, where he served as the Chief People and Places Officer. In addition, he held a variety of executive and senior leadership roles in medical devices, financial services, pharmaceuticals, and engineering.

Some of his past employers are USAA, Petco, State Farm, Fluor, and Walmart. He has had the honor of receiving regional and national recognition for leadership development and culture transformation. Moreover, he has been published on a variety of human capital topics. Mr. Bettinger has an extensive academic background, starting with a bachelor’s degree in communication, a master’s degree in Organizational Communication and Educational Administration from Idaho State University, and a Master’s in Business Administration from Liberty University.

Learn more about: